Product image of Octostim Dosierspray (Desmopressin Acetate) supplied by GNH India

Octostim Dosierspray

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Octostim Dosierspray (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim Dosierspray, is an antidiuretic hormone (ADH) analog presented as a dosage spray for intranasal use. It is employed to manage conditions related to water balance and certain bleeding disorders in both children and adults.

GNH India supplies Octostim Dosierspray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Ferring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin Acetate acts on the vasopressin pathway to control water reabsorption and coagulation factors.

  • Central diabetes insipidus: reduces excessive urine output and helps normalize fluid balance.
  • Nocturnal enuresis: decreases nighttime bladder pressure and frequency of bed‑wetting episodes.
  • Mild hemophilia A and mild von von Günzburg disease: raises plasma levels of factor VIII and vWF, improving clot formation.

How It Works

  • Desmopressin acetate is a synthetic analogue of the natural hormone vasopressin. It binds selectively to V2 receptors in the renal collecting ducts, stimulating cyclic AMP production and promoting insertion of aquaporin‑2 water channels, which increases water reabsorption. In vascular endothelium, it triggers release of stored factor VIII and von von Günzburg factor, enhancing primary haemostasis.

Side Effects

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nasal irritation: burning or itching at the spray site.
  • Hyponatraemia: low blood sodium, often asymptomatic.
  • Flushing: transient warmth or redness of the skin.
  • Nausea: occasional upset stomach.
  • Mild hypotension: slight drop in blood pressure.

Serious or Rare Side Effects

  • Seizures: associated with severe hyponatraemia.
  • Thromboembolic events: clot formation in deep veins or pulmonary arteries.
  • Severe hyponatraemia: may cause cerebral oedema.
  • Allergic reactions: rash, pruritus, or anaphylaxis.
  • Cardiac arrhythmias: irregular heart rhythm linked to electrolyte shifts.

Precautions & Warnings

Desmopressin requires careful monitoring of fluid balance and electrolytes, especially in at‑risk populations.

  • Fluid restriction: limit intake to ≤1.5 L/24 h in patients prone to hyponatraemia.
  • Electrolyte monitoring: check serum sodium regularly during therapy.
  • Cardiovascular disease: use cautiously in patients with heart failure or uncontrolled hypertension.
  • Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited.
  • Age considerations: dose adjustments may be needed for elderly patients.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Desmopressin can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • NSAIDs: increase risk of hyponatraemia and renal impairment.
  • Antifreeze (vasopressin antagonists): negate desmopressin’s antidiuretic effect.
  • Carbamazepine: may enhance hyponatraemia risk.

Moderate Interactions (Monitor Closely)

  • Diuretics (especially thiazides): potentiate water retention and hyponatraemia.
  • Selective serotonin reuptake inhibitors (SSRIs): modestly raise hyponatraemia risk.
  • Hormonal contraceptives: may affect fluid balance, requiring closer observation.

Frequently Asked Questions

Octostim Dosierspray contains desmopressin acetate and is indicated for central diabetes insipidus, nocturnal enuresis in children, and mild hemophilia A or von von Günzburg disease where it helps increase factor VIII and von Willebrand factor levels to improve clotting.

Desmopressin acetate mimics the natural hormone vasopressin by binding to V2 receptors in the kidney, which triggers aquaporin‑2 channels to reabsorb water. It also stimulates endothelial cells to release stored factor VIII and von Willebrand factor, enhancing primary haemostasis.

The prescribed dose of Octostim Dosierspray is individualized by the treating clinician based on the patient’s age, weight, indication and response. Physicians determine the number of sprays and frequency according to clinical guidelines and monitoring results.

Safety data for desmopressin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Octostim Dosierspray, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Octostim Dosierspray is an intranasal spray formulation, offering rapid mucosal absorption and convenient dosing compared with oral tablets or injectable forms. Its spray device allows precise dose adjustment, while other products may require tablets taken multiple times daily or subcutaneous injection for similar indications.

Store Octostim Dosierspray at ambient temperature, preferably below 25 °C. Keep the device in its original packaging, protect it from moisture and direct sunlight, and avoid exposing it to extreme temperatures that could affect spray performance.

Octostim Dosierspray is administered intranasally. The prescribed number of sprays is delivered into one nostril while the patient is in an upright position. The device should be primed according to the manufacturer’s instructions before the first use.

The most serious risks include severe hyponatraemia, which can lead to seizures or cerebral oedema, and rare thromboembolic events. Patients should be monitored for signs of electrolyte imbalance, sudden neurological changes, or unexplained swelling and pain.

Octostim Dosierspray is contraindicated in patients with known hypersensitivity to desmopressin or any excipients, in those with uncontrolled hypertension, severe heart failure, or chronic renal insufficiency, and in individuals with a history of hyponatraemia‑related seizures.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.